AesMed Successfully Exhibits at Cosmoprof Asia 2025

Stepping Into Global Expansion With a New Strategy for 2026

AesMed is pleased to share that our participation in Cosmoprof Asia 2025, held from November 12–14 at the Hong Kong Convention & Exhibition Centre (HKCEC), was a tremendous success. As one of the world’s largest and most influential beauty exhibitions, Cosmoprof Asia provided an exceptional opportunity for AesMed to showcase our innovations in hair and scalp science while connecting with global partners, distributors, and industry professionals.

Showcasing AesMed’s Signature Innovations

During the exhibition, AesMed presented our key product lines and clinical solutions, including:

AGF39™ Cytokines Therapy
A next-generation cytokine-based mesotherapy formulation designed to help normalize the hair cycle and support follicle regeneration.

4th Generation Advance Follicle Shampoo
Featuring a nonionic surfactant base, biocompatible ingredients, and scalp-specific formulas (Dry & Dandruff / Seborrheic), the renewed shampoo line drew strong interest from overseas buyers seeking premium scalp care solutions.

1111 Hair Care Day Campaign
Visitors from various countries expressed interest in collaborating on this global awareness initiative, which highlights empathy, education, and scientific support for alopecia patients each year.
Throughout the exhibition period, AesMed’s booth welcomed numerous international delegates and hair-loss specialists who showed great enthusiasm for our cytokine technology and product portfolio

Expanding Globally: AesMed’s Vision for 2026

Following the successful outcomes of Cosmoprof Asia 2025, AesMed is preparing to accelerate its global business strategy beginning in 2026.

Our global expansion initiatives will include:

• Strengthening partnerships in Asia, Europe, and the Middle East

• Launching AGF39™ and the Advance Follicle Shampoo series in key international markets

• Expanding clinical collaborations with hair-loss treatment hospitals worldwide

• Enhancing our digital and distribution networks for global accessibility

• Developing region-specific education and training programs for cytokine-based alopecia care

AesMed aims to position itself as a world leader in cytokine-driven hair restoration science, delivering scientifically validated, patient-centered solutions to clinics and consumers across the globe.

A Step Toward a Global Future

Our experience at Cosmoprof Asia 2025 marks an important turning point for AesMed. The insights gained, partnerships formed, and global interest received reaffirm that the world is ready for AesMed’s technologies – and we are ready to take the next step.

“Starting in 2026, AesMed will implement a full-scale global expansion strategy to bring our cytokines therapy and scalp care innovations to markets worldwide,”

“We look forward to building long-lasting global partnerships based on science, trust, and shared purpose.”

Thank You for Visiting Us

AesMed extends sincere appreciation to all visitors, partners, and clients who stopped by our booth during Cosmoprof Asia 2025.

This is only the beginning of a new global chapter.

Learn more about our products and upcoming projects: www.aesmed.co.kr


Leave a Comment